Early Briefing and Review: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc.

  Early Briefing and Review: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and
                                 Zogenix Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, August 29, 2013

LONDON, August 29, 2013 /PRNewswire/ --

The U.S. equity market rebounded on Wednesday, August 28, 2013, after falling
sharply in the previous trading session. The S&P 500 rose 0.27% on Wednesday
to finish the day at 1,634.96. The healthcare sector ended on a mixed note as
the broader market finished higher. The major movers in the sector included
Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AbbVie Inc. (NYSE:
ABBV), and Zogenix Inc. (NASDAQ: ZGNX). AAAResearchReports.com has released
free charting and technical research on these aforementioned companies.
Register to read these reports at:

http://www.aaaresearchreports.com/register/ 

Shares in Pfizer Inc. moved higher on Wednesday, reversing some of their
recent losses. The company's shares ended the session 0.77% higher at $28.21
after oscillating between $27.81 and $28.49. A total of 29.22 million shares
were traded which is less than the daily average volume of 55.83 million. The
company's shares have dipped 0.46% in the last three trading sessions,
outperforming the S&P 500 which has lost 1.72% during the same period.
Moreover, the company's shares are trading above their 200-day moving average.
Sign up for free report on PFE at:

http://www.AAAResearchReports.com/PFE082913.pdf

Merck & Company Inc.'s shares fluctuated between gains and losses on Wednesday
before closing the day nearly flat at $47.09. The company's shares traded
between $46.47 and $47.40 before ending the day 0.04% lower than the previous
closing price of $47.11. A total of 9.81 million shares traded, which is
below the daily average volume of 15.13 million. The company's shares have
declined by 1.11% during the last three months, compared to a loss of 1.51% in
the S&P 500 during the same period. Despite the recent losses, Merck & Company
Inc.'s stock continues to trade above its 200-day moving average. MRK free
technical report can be accessed by signing up at:

http://www.AAAResearchReports.com/MRK082913.pdf

AbbVie Inc.'s stock ended slightly lower on Wednesday, finishing at $42.56,
down 0.16% from its previous closing price of $42.63. The company's shares
oscillated between $42.35 and $42.81. A total of 3.00 million shares were
traded, which is below the daily average volume of 4.47 million. AbbVie Inc.'s
shares have lost 4.98% in the last one month, underperforming the S&P 500
which has lost 3.35% during the same period. Further, the company's shares are
trading below its 50-day moving average. A free report on ABBV can be accessed
by registering at:

http://www.AAAResearchReports.com/ABBV082913.pdf

On Wednesday, shares in Zogenix Inc. rose sharply, tracking gains in the
broader market. The company's shares ended the day at $1.56, up 1.96%, after
fluctuating between $1.53 and $1.58. A total of 0.10 million shares were
traded, which is below the daily average volume of 0.45 million. Moreover, the
company's shares have gained 2.63% in the previous three months, outperforming
the S&P 500, which has fallen by 1.51% during the same period. Moreover,
Zogenix Inc.'s shares are trading below their 50-day and 200-day moving
averages. Register with AAA Research Reports and download research on ZGNX for
free at:

http://www.AAAResearchReports.com/ZGNX082913.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA ® charterholder. However, we are only human
    and are prone to make mistakes. If you notice any errors or omissions,
    please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

AAAresearchreports.com

SOURCE AAA Research Reports

Contact: Phone #: +1(646)396-9126, Peter F. Jones, Email ID:
info@aaaresearchreports.com